Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이양순 | - |
dc.date.accessioned | 2018-02-22T07:57:08Z | - |
dc.date.available | 2018-02-22T07:57:08Z | - |
dc.date.issued | 2011-10 | - |
dc.identifier.citation | Laboratory Medicine Online, Vol.1 No.4 [2011], 209-220(12쪽) | en_US |
dc.identifier.issn | 2093-6338 | - |
dc.identifier.uri | https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001593271 | - |
dc.identifier.uri | http://hdl.handle.net/20.500.11754/39959 | - |
dc.description.abstract | Background: β-lactam antibiotics are one of the most common antimicrobial agents. However, the increasing of β-lactamase-producing bacteria makes these agents less useful. Therefore, agents stable for β-lactamase have been developed. This study was conducted to determine the activities of the combination agent ceftriaxone-sulbactam and to compare its activities with other agents. Methods: A total of 437 clinical isolates of aerobic and anaerobic bacteria were collected in Severance Hospital from 2007 to 2011. Using 23 antimicrobial agents, antimicrobial susceptibility tests were performed using the Clinical and Laboratory Standards Institute (CLSI) agar dilution method. Results: The minimal inhibitory concentrations (MICs) of ceftriaxone and ceftriaxone-sulbactam were similar to or lower than those of other β-lactam antibiotics for methicillin-susceptible Staphylococcus aureus (MSSA), Streptococcus pneumoniae, S. pyogenes, and viridans group streptococci. For Moraxella catarrhalis, Neisseria gonorrhoeae, Haemophilus influenzae, and H. parainfluenzae, ceftriaxone and the ceftriaxone-sulbactam combination also show low MIC_(50) and MIC_(90). For extended-spectrum β-lactamase (ESBL)-producing E. coli, the MICs of ceftriaxone-sulbactam were lower than those of other cephalosporins. Among the anaerobes, ceftriaxone-sulbactam showed good activity compared to ceftriaxone alone for the Bacteroides fragilis group, B. thetaiotaomicron, other Bacteroides sp., Prevotella sp., and Porphyromonas sp. Conclusions: Ceftriaxone-sulbactam showed good antimicrobial activity and thus is useful for the treatment of infections by MSSA, S. pneumoniae,S. pyogenes, viridans group streptococci, M. catarrhalis, N. gonorrhoeae, H. influenzae, H. parainfluenzae, E. coli, and K. pneumoniae, B. fragilis group, B. thetaiotaomicron, other Bacteroides sp., Prevotella sp., and Porphyromonas sp. | en_US |
dc.description.sponsorship | This work was supported a grant from Korea Pharma Co. Ltd. | en_US |
dc.language.iso | ko_KR | en_US |
dc.publisher | 대한진단검사의학회 | en_US |
dc.subject | Antimicrobial susceptibility test | en_US |
dc.subject | ceftriaxone | en_US |
dc.subject | sulbactam | en_US |
dc.subject | combination | en_US |
dc.title | Ceftriaxone-sulbactam의 주요 호기성 및 혐기성 임상 분리균주에 대한 시험관내 항균력 | en_US |
dc.type | Article | en_US |
dc.relation.no | 4 | - |
dc.relation.volume | 1 | - |
dc.identifier.doi | 10.3343/lmo.2011.1.4.7 | - |
dc.relation.page | 209-220 | - |
dc.relation.journal | Laboratory Medicine Online | - |
dc.contributor.googleauthor | 조선미 | - |
dc.contributor.googleauthor | 정혜선 | - |
dc.contributor.googleauthor | 김명숙 | - |
dc.contributor.googleauthor | 용동은 | - |
dc.contributor.googleauthor | 정석훈 | - |
dc.contributor.googleauthor | 이경원 | - |
dc.contributor.googleauthor | 정윤섭 | - |
dc.contributor.googleauthor | 이양순 | - |
dc.contributor.googleauthor | Cho, Sunmi | - |
dc.contributor.googleauthor | Chung, Hae-Sun | - |
dc.contributor.googleauthor | Kim, Myungsook | - |
dc.contributor.googleauthor | Yong, Dongeun | - |
dc.contributor.googleauthor | Jeong, Seok Hoon | - |
dc.contributor.googleauthor | Lee, Kyungwon | - |
dc.contributor.googleauthor | Chong, Yunsop | - |
dc.contributor.googleauthor | Lee, Yangsoon | - |
dc.relation.code | 2012233347 | - |
dc.sector.campus | S | - |
dc.sector.daehak | COLLEGE OF MEDICINE[S] | - |
dc.sector.department | DEPARTMENT OF MEDICINE | - |
dc.identifier.pid | yangsoon | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.